AR095097A1 - Compuestos de fenoxietoxi - Google Patents
Compuestos de fenoxietoxiInfo
- Publication number
- AR095097A1 AR095097A1 ARP140100313A ARP140100313A AR095097A1 AR 095097 A1 AR095097 A1 AR 095097A1 AR P140100313 A ARP140100313 A AR P140100313A AR P140100313 A ARP140100313 A AR P140100313A AR 095097 A1 AR095097 A1 AR 095097A1
- Authority
- AR
- Argentina
- Prior art keywords
- phenoxyetoxi
- compounds
- refers
- compound
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
Abstract
La presente se refiere a un compuesto de la fórmula (1) o una sal del mismo farmacéuticamente aceptable.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361765057P | 2013-02-15 | 2013-02-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR095097A1 true AR095097A1 (es) | 2015-09-30 |
Family
ID=50102283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140100313A AR095097A1 (es) | 2013-02-15 | 2014-01-30 | Compuestos de fenoxietoxi |
Country Status (4)
Country | Link |
---|---|
US (1) | US9000043B2 (es) |
AR (1) | AR095097A1 (es) |
TW (1) | TW201443004A (es) |
WO (1) | WO2014126746A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3083562B1 (en) | 2013-12-17 | 2017-09-27 | Eli Lilly & Company | Phenoxyethyl cyclic amine derivatives and their activity as ep4 receptor modulators |
CR20180323A (es) | 2015-11-20 | 2018-08-06 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituídos como moduladores de los receptores de pge2 |
MX2019013639A (es) | 2017-05-18 | 2020-01-21 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituidos. |
ES2896476T3 (es) | 2017-05-18 | 2022-02-24 | Idorsia Pharmaceuticals Ltd | Derivados de pirimidina |
EA201992677A1 (ru) | 2017-05-18 | 2020-04-23 | Идорсия Фармасьютиклз Лтд | Пиримидиновые производные в качестве модуляторов pge2 рецепторов |
MX2019013718A (es) | 2017-05-18 | 2020-01-30 | Idorsia Pharmaceuticals Ltd | Derivados de pirimidina como moduladores del receptor de pge2. |
AR111807A1 (es) | 2017-05-18 | 2019-08-21 | Idorsia Pharmaceuticals Ltd | Derivados de benzofurano y benzotiofeno como moduladores del receptor pge2 |
GB201914585D0 (en) * | 2019-10-09 | 2019-11-20 | Heptares Therapeutics Ltd | Prostaglandin ep4 receptor antagonist compounds |
WO2022102731A1 (ja) | 2020-11-13 | 2022-05-19 | 小野薬品工業株式会社 | Ep4拮抗薬と免疫チェックポイント阻害物質との併用によるがん治療 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004268839A1 (en) | 2003-09-03 | 2005-03-10 | Pfizer Inc. | Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists |
AP2006003769A0 (en) | 2004-05-04 | 2006-10-31 | Pfizer | Ortho substituted aryl or heteroaryl amide compounds |
CN107693518A (zh) | 2010-02-22 | 2018-02-16 | 株式会社AskAt | Ep‑4受体拮抗剂在治疗il‑23介导疾病中的用途 |
-
2014
- 2014-01-29 TW TW103103688A patent/TW201443004A/zh unknown
- 2014-01-30 AR ARP140100313A patent/AR095097A1/es unknown
- 2014-02-04 WO PCT/US2014/014534 patent/WO2014126746A1/en active Application Filing
- 2014-02-04 US US14/171,817 patent/US9000043B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20140235718A1 (en) | 2014-08-21 |
TW201443004A (zh) | 2014-11-16 |
US9000043B2 (en) | 2015-04-07 |
WO2014126746A1 (en) | 2014-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20150418A (es) | Compuestos de tetrahidropirrolotiazina | |
AR110381A2 (es) | Inhibidores biarilo de tirosina cinasa de bruton | |
CR20150078A (es) | Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn | |
AR095097A1 (es) | Compuestos de fenoxietoxi | |
PE20160862A1 (es) | Polimorfo de los inhibidores de la syk | |
AR098274A1 (es) | Inhibidor de grelina o-acil transferasa | |
AR101995A1 (es) | COMPUESTOS ANTAGONISTAS DE INTEGRINA avb6 | |
UY35333A (es) | Compuestos de azabencimidazol | |
EA201591634A1 (ru) | Дигидропиридопиримидиновые соединения | |
CR20140468A (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
DOP2014000250A (es) | Nuevos compuestos de pirazol | |
AR105821A1 (es) | COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T | |
EA201690894A1 (ru) | Феноксиэтилы | |
EA201592268A1 (ru) | Дигидропиридиноновые ингибиторы mgat2 | |
CR20150325A (es) | Compuestos trcíclicos para inhibir el canal cftr | |
EA201591915A1 (ru) | Соединения феноксиэтил дигидро-1h-изохинолина | |
JO3742B1 (ar) | مركب بيرانو داي بيريدين | |
CO2019005165A2 (es) | Compuesto de piridona como inhibidor de c-met | |
CR20140114A (es) | Compuestos de benzotiazolona | |
AR124083A2 (es) | Nuevo inhibidor de sglt1 | |
CL2019000487A1 (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana. | |
CL2017002651A1 (es) | Derivados de aminohidrotiazina fusionados con tetrahidrofurano los cuales son útiles en el tratamiento de la enfermedad de alzheimer | |
ES2571452T3 (es) | Compuesto antagonista de leucotrieno B4 | |
AR092627A1 (es) | Derivados glucopiranosidos de urea | |
DOP2016000062A (es) | Derivados de indol-urea de glucopiranosil sustituido y su uso como inhibidores de sglt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |